Funding
← Back to your selection

NAVER D2SF

Activity from announced rounds

Activity in this selectionMar 31, 2026 · Mar 1, 2026

NAVER D2SF is NAVER’s startup investment organization, identified through official materials for ImpriMed and NdotLight.

Recorded funding activity

ImpriMed combines live-cell drug testing with clinical data. NdotLight generates simulation-ready 3D data, while F4GE structures factory information for industrial buyers. The organization retains its identity separately from NAVER Ventures and the parent.

Sources
Rounds participated in
4
Confirmed lead rounds
0
3 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
—
0 disclosed · full round size, not this investor’s share

By stage

Undisclosed3
Pre-seed1

By primary sector

Healthtech2
Robotics2

By country

South Korea2
United States2

Rounds

4 in this selection
Soundable Health

Develops AI-powered acoustic analysis for clinical-grade diagnostics through everyday devices

UndisclosedUndisclosed
Role not disclosed
Nuvilab

Develops AI-powered nutrition analytics solution for healthcare

UndisclosedUndisclosed
Role not disclosed
Anyware Robotics

Anyware Robotics builds mobile robots and control software for physically demanding material-handling work in warehouses and industrial facilities.

UndisclosedInvestment
Participant